Pacira BioSciences' Deferred Taxes rose 62394.62% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 4210.59%. This contributed to the annual value of $20.6 million for FY2024, which is 3205.89% up from last year.
Per Pacira BioSciences' latest filing, its Deferred Taxes stood at $8.1 million for Q3 2025, which was up 62394.62% from $752000.0 recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Deferred Taxes registered a high of $12.5 million during Q2 2024, and its lowest value of -$10.8 million during Q4 2022.
For the 5-year period, Pacira BioSciences' Deferred Taxes averaged around $2.6 million, with its median value being $2.2 million (2022).
In the last 5 years, Pacira BioSciences' Deferred Taxes crashed by 2541724.14% in 2023 and then skyrocketed by 62394.62% in 2025.
Quarter analysis of 5 years shows Pacira BioSciences' Deferred Taxes stood at -$2.1 million in 2021, then tumbled by 420.9% to -$10.8 million in 2022, then soared by 160.89% to $6.6 million in 2023, then tumbled by 46.86% to $3.5 million in 2024, then surged by 130.1% to $8.1 million in 2025.
Its Deferred Taxes was $8.1 million in Q3 2025, compared to $752000.0 in Q2 2025 and $1.4 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value